| Ytd | -16.10% | |
| 1y | 103.87% |
| Open | 13.76 | Prev Close | 13.81 | Low | 12.73 | High | 13.76 | Mkt Cap | 384.75M |
| Vol | 90.33K | Avg Vol | 211.47K | EPS | -2.59 | P/E | -5.11 | Forward P/E | -1.32 |
| Beta | 0.98 | Short Ratio | 20.91 | Inst. Own | 100.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 13.07 | 200-d Avg | 13.37 | 1yr Est | 16.88 |
ENTA News
Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $0.67 per share versus the Zacks Con
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
Enanta Pharmaceuticals (ENTA) was a big mover last session on higher-than-average trading volume. Th
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
US stock futures lower, Braze Inc (BRZE) shares drop 8.4% in pre-market trading after reporting mixe
[url="]Enanta Pharmaceuticals, Inc.[/url] (NASDAQ: ENTA), a clinical-stage biotechnology company ded
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Oth
Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $0.45 per share versus the Zacks Con
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
Enanta Pharmaceuticals (ENTA) witnessed a jump in share price last session on above-average trading
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biot
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA - Get Free Report) passed below its 200-day moving averag
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
Enanta Pharmaceuticals (ENTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimis
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $0.42 per share versus the Zacks Con
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biot
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The comp
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announce
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market ses
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quart
Tuesday saw 132 companies set new 52-week lows.
On Thursday, 369 companies hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
During Thursday's session, 406 companies made new 52-week lows.
On Thursday, 283 companies set new 52-week lows.
On Wednesday, 179 companies reached new 52-week lows.
On Tuesday, 164 companies achieved new lows for the year.
During Tuesday's trading, 188 companies set new 52-week lows.
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss a
During Wednesday's session, 212 companies made new 52-week lows.
On Tuesday, 164 companies hit new 52-week lows.
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 pe
On Thursday, 185 companies achieved new lows for the year.
On Wednesday, 345 companies set new 52-week lows.
Tuesday's session saw 286 companies set new 52-week lows.
On Monday, 147 stocks made new 52-week lows.